ArticleData in brief2024
Evaluation and utilisation of privacy enhancing technologies-A data spaces perspective.
Article in Data in brief, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Beyond classical models: LLM-driven survival analysis for breast cancer prognosis using European cancer registry data.BMC medical informatics and decision making · 2026Article
- Homomorphic encryption for privacy-preserving data aggregation in data spaces.Data in brief · 2026Article
- Secondary use under the European Health Data Space: setting the scene and towards a research agenda on privacy-enhancing technologies.Frontiers in digital health · 2025Article
- Synthetic data in medical imaging within the EHDS: a path forward for ethics, regulation, and standards.Frontiers in digital health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data sharing has facilitated the digitisation of society. We can access our bank accounts or make an appointment with our doctor anytime and anywhere. To achieve this, we have to share certain information, whether personal, professional, etc. This may seem like a minor cost for an individual user, but actually the data economy as the backbone of a digital transformation that is reshaping all aspects of human life. However, one of the major concerns arises regarding what happens to such individual data; once shared, control over it is often lost. For that reason, users and companies are reluctant to share their data. The European Union, through its European Strategy for Data, is establishing a policy and legal framework for establishing a single market for data in Europe by improving the trust and fairness of the data economy. Data spaces are a commitment to sharing data in a reliable and secure way, but this endeavour should, of course, not be at the expense of privacy rights. In recent years, Privacy-Enhancing Technologies (PETs) have emerged to achieve data sharing and privacy preservation that can address the requirements of data spaces around sensitive citizen and business data. In this work, we review existing PETs and assess their relevance, technological maturity, and applicability in the context of common European data spaces. Finally, we illustrate the benefits of secure data sharing via Federated Learning in a healthcare use case, where the preservation of privacy is a primer requirement and is therefore to be guaranteed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.